Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.580
+0.010 (0.39%)
Mar 10, 2026, 4:00 PM EDT - Market closed
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $68.38 million as of March 10, 2026. Its market cap has increased by 78.12% in one year.
Market Cap
68.38M
Enterprise Value
53.09M
1-Year Change
78.12%
Ranking
Category
Stock Price
$2.58
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $68.38M, an increase of 9.39%. That is a compound annual growth rate of 1.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 68.38M | -25.43% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coeptis Therapeutics Holdings | 72.31M |
| XBiotech | 71.65M |
| Cingulate | 71.37M |
| Q32 Bio | 71.25M |
| TScan Therapeutics | 70.56M |
| Actuate Therapeutics | 68.80M |
| MediciNova | 67.93M |
| Impact BioMedical | 66.84M |